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Long-Term Hematopoietic Damage:
Concepts, Approaches, and Results
Relevant to the Study of Environmental
Toxins
by Nydia G. Testa* and Thomas M. Dexter*
The hematopoietic tissue is one ofthe prime examples ofhierarchical tissues, where mature cells with a
limited life span are continually replaced as aresult ofproliferation and differentiation from stem andpro-
genitor cells. In the bone marrow, these processes are controlled by growth factors andby cell to cell inter-
actions, the latter being specially important for the regulation ofthe stem-cell population. In the study of
long-term hematopoietic damage, we have to distinguish between deleterious effects ofthe environmental
toxins on the stem andprogenitorcells, and on the stromal bone marrow cells which arepart ofthe regula-
tory hematopoietic microenvironment. In some experimental situations, the function ofthe tissue may be
subnormal, not because ofstem cell damage (which may also be present), but becguse ofdamage to regula-
tory environmental populations. Because ofthehigh degree oforganization ofthe hematopoietic tissue (not
immediately obvious from histological sections), theheterogeneity ofthe stromal cellpopulations, andtheir
different capacities to regenerate after cytotoxic insult, the stromal damage is likely to be heterogeneous
andwouldtendtobeexpressed functionally atlatertimes than acute hematopoietic injury. While microen-
vironmental damage may be ofimportance in the induction ofhematopoietic failure, theprimary target in
leukemogenesis is likely to be the stem cell. However, experimental data support the concept that regula-
tory microenvironmental influences may hinder or favor the development of leukemia.
Introduction
The continuous physiological replacement ofvast num-
bers ofmature hematopoietic cells isthe end resultofor-
dered processes ofcell proliferation, differentiation, and
maturation that start at the level ofhematopoietic stem
cells. Stem cellsgenerate progenitor cell populations with
more limited proliferation capacity, which are able to
differentiate only along one or two hematopoietic line-
ages. Progenitor cells will, in turn, give rise to the more
mature cells that are recognizable morphologically and
that comprise about99% ofthe hematopoietic cells inthe
bone marrow.
The hematopoietic tissue has the capacity to respond
quickly and effectively to increased demand for mature
cells, for example, to replace blood loss orto dealwith in-
fection and can maintain this response for prolonged
periods oftime. The finelytunedmechanisms involved in
theregulation ofprogenitor cells are becomingrelatively
understood, but less is known about the regulation of
stem cells, either their self-reproduction (a crucial factor
in maintaining hematopoietic function in the long term)
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or their commitment to differentiation. Here, we shall
analyze the relative contribution ofdamage to stem and
progenitorcellpopulationsandtotheregulatorymicroen-
vironment withinwhich hematopoiesis takes place to the
long-term function ofthe tissue.
Structure of the Hematopoietic
Tissue
The first clonal assay in experimental hematology was
based onthe observation that afterthe injection ofbone
marrow cellsintolethally irradiatedmice, some ofthe in-
jected cells (CFU-S) lodge in the spleen and, by clonal
proliferation, give rise-to visible colonies that contain not
onlycells ofseveralhematopoietic andlymphoidlineages,
but also cells able to generate further spleen colonies
upon retransplantation (1-3).
There is, however, great heterogeneity in the meas-
uredpotential ofthe spleencolony-forming cells: some of
the CFU-S are not multipotential or able to self-
reproduce, and may only be able to give rise to commit-
ted progenitors and to cells of only one hematopoietic
lineage (4,5). However, at least some spleen colony-
formingcells canbeequated to stemcells, andthe CFU-S
assayremainswidelyused as anindirect, butreliable, es-
timate ofthe stem cell capacity of the tissue in severalTESTA AND DEXTER
experimental approaches. The existence ofstem cellshas
been elegantly demonstrated by showing that the
hematopoietic and lymphoid systems of a potentially
lethally irradiated mouse can be repopulated by the
progeny of a single cell, which can be detected by the
presence ofeither a chromosome marker or an inserted
retroviral marker(6,7). Amultipotential cell, whichover-
laps with and is able to generate CFU-S, is the murine
mixed colony-forming cell (Mix-CFC), detected by an in
vitro clonal assay(8). A similar cell canbe detected inhu-
mans (9). Committed progenitor cells (CFCs) that give
rise to the different hematopoietic lineages are also
studied using in vitro clonal assays (10) where they are
induced to proliferate in response to hematopoietic
growth factors(colony-stimulating factors, CSFs). The hi-
erarchical organization ofthese cellpopulationsis shown
in Figure 1.
Regulation of Hematopoiesis
The hematopoietic growth factors, commonlyreferred
to as colony-stimulating factors (CSFs) (Table 1) (11-14)
werefirst detectedby theircapacity toinduce prolifera-
tion andmaturation ofcolonyformingcellsinvitro. Some
ofthem appear to be largely lineage restricted, with M
(macrophage)CSF acting on cellswhoseproliferation will
result only in the production of macrophages, and G
(granulocyte)-CSF, inducing production of neutrophilic
granulocytes. In contrast, interleukin 3 (IL-3) will pro-
mote not only the development ofthe committedprogen-
itorcells, butwill also stimulate the development ofMix-
CFC. Similarly, GM-CSF willnotonly stimulate thepro-
duction of neutrophilic granulocytes and macrophages,
but will also stimulate progenitor cells to produce eo-
sinophils andmegakaryocytes. Thesetwofactorswill also
induce red cell development from primitive progenitor
cells in the presence oferythropoietin. Othergrowthfac-
tors isolated more recently may also have awiderrange
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ofaction thaninitially thought (Table 1). Othermolecules,
collectively described as biological response-modifiers,
can influence hematopoiesis directly or indirectly, al-
though by themselves they do not act as growth factors
(i.e., they cannot induce colony formation by progenitor
cells). They include prostaglandins, interferons, tumor
necrosisfactor, andtransforminggrowthfactors. Among
them there are also some interleukins that have effects
onmyeloid andlymphoid cells, buttheirmode andrange
ofactionhaveyettobe established. Acomprehensive list
ofeffects is foundinO'Garraetal. (15). Themostrelevant
here is interleukin 1 (IL-1)which, per se, does not stimu-
late colony formation. In this context, it was first
described as apotentiation factor calledhematopoietin 1,
which induces primitive progenitor cells into a state in
which they are able to respond to M-CSF stimulation,
withproduction ofmacrophages (14). Whetherthisisthe
only, or eventhemain effect ofIL-1 on hematopoiesis re-
mains to be determined.
The role ofgrowth factors in hematopoiesis was eluci-
dated by devising experimental in vitro systems where
the actionofpurifiedfactorsonpurifiedtargetcells could
be investigated. However, the bonemarrow is acomplex
heterogeneous tissue with a well-defined anatomical
structure. Although bone marrow sections examined
microscopically show an apparently random collection of
cells, determinations ofthe incidence ofcolony-forming
cells and nonhematopoietic stromal cells show anonran-
dom, nonhomogeneous distribution ofdifferent cellpopu-
lations withinthemarrow spacein mice(12). The datafor
humans is more limited (16). Also, cell populations that
produce regulatory factors are more concentratedin cer-
tain areas. Thispresumably leads to different regulatory
influences beingexerted inlocal domains. By usinglong-
termbone marrow cultures, ithasbeenestablishedthat
complex cellinteractions influence the growth and devel-
opment of stem cells. In these cultures stromal cells
(fibroblastic-reticular cells, adipocytes, endothelial cells)
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FIGURE 1. Cell hierarchies in hematopoiesis.
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Table 1. Growth factors and target in vitro colony-forming cells (CFC).
Erythroid
Granulocyte- Early Late
Growth factor Mix macrophage CFC CFC Megakaryocytic Eosinophilic
IL-1 + ?
IL-3 + + + + + +
IL-4 + + + + + ?
IL-5 - - - -
IL-6 ? ? ? ? ? ?
GM-CSF -/+ + -/+ - + +
M-CSF - +
G-CSF _ + _ _
Megacaryocytes-CSF - - - - +
Erythropoietin - - - + +
a(+) Stimulation; (-) no effect; (?) not known.
form acomplexmultilayerattached to the surface ofcul-
tureflasks, formingamicroenvironmentwithinwhichac-
tive hematopoiesis may take place for several months
(14). Hematopoietic growth factors, such as M-CSF and
GM-CSF maybeproduced withinthe adherentlayer, but
theyarenotreleasedatsignificant levelsinto thegrowth
medium. IL-3, however, has not been detected in such
cultures(14). This culture system, unliketheclonalassays
for progenitor cells, allows sustained renewal and
differentiation ofstem cells. These events are likelytobe
crucially influenced by the capacity ofstem cells to bind
to stromal cells, a step critical before stromal cell-bound
regulatory factors may influence them. This step may
also be needed before growth factors bound to extracel-
lular matrix molecules (themselves cell-bound?) (14,1?)
may interact with the stem cells.
Itfollows that events thatmay damage the regulatory
milieu of stem cells can be studied using long-term cul-
tures. Aswill be seen fromthefollowing discussions, in-
stances where defects in the regulatory stroma may be
the causative factor in subnormal hematopoiesis have
been documented.
Long-Term Hematopoietic Injury
More is known aboutlong-term damage aftercytotoxic
agents (drugs and radiation) used as therapy for malig-
nant disease than about the effect of environmental
toxins. Clearly, one important reason for this is that
studies relevant to the therapy ofmalignancyusually deal
with maximum tolerated doses where doses are known
and where clear effects areobserved, whereas afrequent
problem in environmental studies is to decide where a
dose threshold lies (and, indeed, whether a threshold
exists). Also, determining dose-effect relationships by
measuringbiological effects that are close to thelimits of
methodological resolution is aproblem afterlow doses of
toxins.
Fundamental differences, forexample, indrugmetab-
olismbetween species ofmammalsusedinexperimental
work and between these mammals and humans compli-
cate the assessment ofdamage. However, epidemiology
can establish convincing associations between
hematopoietic damage and environmentaltoxins, evenif
the degree, type, andextensionofsuch damagemaynot
be easily determined. Here, we shalluseexamples ofex-
perimental studies using drugs or radiation to illustrate
typesofhematopoieticdamageand theadaptiveresponse
ofthe tissue, which may be relevant to the study ofen-
vironmental toxins.
Stem Cell Damage Versus
Microenvironmental Damage
Direct damage to stem cellsistobe expectedafterex-
posure to cytotoxic agents. Just depletion of stem cell
numbers, however, is not alikely cause ofhematopoietic
failure leading to hypoplasia or aplastic anemia. It is
known that the CFU-S population is not reduced after
recovery from severe and repeated proliferation stress
inducedby depletion in situ. Repeatedadministration of
triethilenmelamine (18) orhydroxyurea(19) at dosesthat
each produced a depopulation of the order of 99% of
CFU-S, was followed by recovery of CFU-S to normal
numbers(18). Furthermore, the quality ofthese cells,i.e.,
their self-reproduction capability, was maintained (19).
After depletion by other treatments, however, CFU-S
numbersneverrecovertocontrollevels(20). Afterdeple-
tionbybusulphan, aphaseofexponentialgrowthfollows,
but CFU-S reach only abouthalfthe numbers inthe un-
treated controls. Suboptimal plateau numbers ofCFU-S
are also found after treatment with other agents (20).
There are several interesting features in these new
steady states that may follow drug treatment:
a)Thelevel towhich the CFU-S recoveris notrelated
to the acute CFU-S kill. Over arange ofdoses up to the
maximumtolerated dose, followingsingle orrepeated ad-
ministration of busulphan, cyclophosphamide or bis-
cloroethyl nitrosourea (BCNU), the CFU-S recoverto a
level characteristic ofthe drugbut are not influencedby
the dose used (21-23). The level is stable for the rest of
the life-span of the mice. After radiation, however, the
level ofthe suboptimal plateau is related to dose.
b) The GM-CFC population plateaus at a higher level
than the CFU-S (22,23).
c) In spite ofaandb above, themature cell output(i.e.,
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peripheral blood counts) may be normal because of
several compensatory mechanisms (e.g., increased am-
plification from the progenitor cell compartment) that are
called into action (16). However, when the system is
stressed by transplantation, fewer cells are produced
than in controls (22). Also, in some cases, notably after
busulphan, alate hypoplasia develops (24)in the treated
mice. A similar picture may develop afterrepeated radi-
ation treatment (25). It is not clear whether this syn-
drome should be considered as a preleukemic state.
d) The suboptimal plateau in CFU-S, seen after treat-
mentwith some cytoreductive regimes, is not determined
by a reduced self-reproduction or proliferation capacity
of these cells (although those effects may be present).
When transplanted into appropriate recipients the
CFU-S are capable offastexponentialgrowth and often
complete regeneration ofthe hematopoietic system.
Thus, it is clearthat the subnormnalhematopoiesis that
may be seen in treated mice may not be (or at least not
primarily) a functionofstem cell damage. In many cases
the subnormal plateau in CFU-S numbers could well be
a limitation imposed on them by a damaged regulatory
microenvironment. There is other evidence ofmicroen-
vironmental damage as the main course of disturbed
hematopoiesis afterinjury: Following treatment with cy-
clophosphamide, the CFU-S with the highest self-
reproduction capacity are spared selectively. From this,
one would expect a good reconstitution of the CFU-S
compartment. However, as stated earlier, subnormal
numbers are observed andin aminority ofmice there is
serious hematopoietic damage manifested as hypoplasia
ormyelodysplasia(21). That this maybe associated with
damage tothemicroenvironment isindicatedbythefind-
ingthat astromal cellpopulation ofreticularfibroblastoid
cells is also subnormal (21). There is also evidence that
microenvironmental abnormalities may cause aplastic
anemia in humans (26-29).
In the context of microenvironmental damage by
toxins, it is important to consider notonlywhatthebasic
lesions are, but also (and perhaps more importantly)
which are thelimitingfactors that govern cellproduction
whenhypoplastic syndromes are considered. Itwould ap-
pear from the experimental data reviewed previously
that even in the presence of stem cell damage, the cru-
cialfactor in determining thelevel ofhematopoiesis is the
damage to the regulatory microenvironment. When in-
duction ofleukemia is considered, damage to stem cells
is the most likely primary consideration. Microenviron-
mental influences, however, are also likely to play arole
in leukemogenesis. It is known that myeloid leukemic
cellsrespond to hematopoieticgrowthfactors, andindeed
require them forgrowth in vitro (30). Furthermore, the
regulatory stromainlong-term culturesfavors the reap-
pearance of normal hematopoiesis when bone marrow
from patients with acute myeloblastic leukemia is cul-
tured. The leukemic clonal cells may become undetecta-
ble, and normal, presumably polyclonal, cells reappear
and become predominant (31,32).
Assays for the Study of
Microenvironmental Damage
Several assays to study the hematopoietic microen-
vironment are listed in Table 2. The first described is a
clonal assay that detects a cell population (CFU-F) able
to give rise to colonies offibroblastoid-reticular cells in
culture (33). Persistent lownumbers ofCFU-F are found
after acute recoveryfrom treatmentwithbusulphan (fol-
lowing a pattern strikingly similar to that shown by
CFU-S) and also after cyclophosphamide or radiation
(21,23,25).
Implantation of femoral bone SC in mice results in
colonization ofthe bone cavity by hematopoietic cells of
the host, supportedby the donor stromawhich develops
in situ. Low numbers of CFU-S are supported by the
stromaofbusulphan-treated mice (35). Furtherevidence
of microenvironmental damage after busulphan is ob-
served after implanting bone marrow tissue under the
kidney capsula ofmice, a technique originally described
by Friedenstein et al. (36). Inthis assay, adonor-derived
microenvironment develops at the site ofimplantation,
which is able to support host-derivedhematopoiesis. The
environment provided by marrow from busulphan-
Ts.ble 2. Methods for the study ofthe microenvironment.a
Method Species Parameters studied
CFU-Fb assay Guinea pig, mouse, human, rabbit, Colony forming incidence, cell type, production of
rat, cat collagen, production of CSF
Long-term bone marrow cultures Mouse, human, tree-shrew, cat Hematopoiesis, stem and progenitor cell production,
production ofhematopoietic growth factors, study of
the extracellular matrix, normal and leukemic cell
differentiation, types and function of stromal cells
Subcutaneous implants Mouse (femoral shaft)c Hematopoietic foci, origin of stromal and hematopoietic
Rabbit (bone marrow, demineralized cells, bone formation, fat accumulation, production
bone)c of CSF, production ofcollagen
Implants under the kidney capsule Guinea pig, rabbit, mouse (bone Bone formation, hematopoietic foci, origin of stromal
marrow, cultured fibroblasts)c and hematopoietic cells
aMethodology reviewed in Testa and Gale (42).
bCFU-F, colony-forming unit, fibroblastic. crlssues in parentheses are implants.
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treated mice is able to support hematopoiesis only at
about 50% of the control level (23).
In long-term bone marrow cultures active hematopoi-
esis depends, as described above, on the formation ofa
complex adherent layer ofstromal cells (14). The level of
hematopoiesis depends on the functional integrity ofthe
stroma. When normal bone marrow cells are inoculated
ontopreformed adherent stromal celllayers derivedfrom
marrow of busulphan-treated mice, the microenviron-
ment they provide is only able to support about 20% of
the level of hematopoiesis seen in cultures where the
stroma was providedby marrow ofuntreated mice (37).
Inthe converse experiment, wheremarrowfromtreated
mice wasinoculated on normaladherentlayers, thelevel
of hematopoiesis was about 80% of controls (normal on
normal). This againindicates thatthe limiting factorhere
is the microenvironmental, not the stem cell damage. A
similar situation is found after chemotherapeutic treat-
ment for lymphoblastic leukemia (38). The considerable
reserve capacity of stem cells to respond to intensive
proliferative stress, calculated to be able to support
hematopoiesis foratleastfive life-spans in mice(39), may
still be considerable even in a damaged stem cell popu-
lation that is consequently able to comply with the de-
mands for mature cell production. However, drugs and
chemicals, unlike radiation, may have selective effects on
certain subpopulations ofthe stem cell hierarchy. Those
agentsthat damage the earliestcells(i.e., those cellswith
thehighest self-reproduction and repopulation capacity)
are more likely to induce stem cell failure than those that
hit selectively more mature populations (20).
The capacity ofstromal cells to recoveraftercytotoxic
injury is likely to be considerably less than that shown
by stem cells. At least some types of stromal cells have
a slow turnover (40) and may also have a long life-span.
Considerable differences in those parameters in the dif-
ferenttypes ofstromal cells is also tobe expected. Also,
injury to themmaytake alongtime tobe expressedfunc-
tionally. For example, the microenvironmental cells in
long-termbonemarrow cultures canbe sterilizedbylarge
doses of radiation, but they remain able to support
hematopoiesis for 4 to 6 weeks (41). It is only when the
sterilized cells attempt to divide that they will be elimi-
nated. In this context it is ofinterest to note that tran-
sient normalization ofCFU-S may be observed at about
100 days afterbusulphantreatment. Normalvalues, how-
ever, are notmaintained (23). Anotherimportantconcept
is that not only the integrity ofseveral cell populations
(with differentlife-spans and differentproliferativepoten-
tial to recoverafterinjury)maybe requiredforadequate
regulatoryfunction, but also the correct cell associations
may have to take place and the correct ratios of differ-
ent cell types maintained (42).
Studies ofthehematopoietic system afterexposure to
benzene have so far concentrated on the acute injury.
These studies have demonstrated that CFU-S and CFCs
are sensitive targets for this agent. However, microen-
vironmental damage has also been reported. These data
are reviewed elsewhere in this volume. Long-term
studies ofhematopoietic and stromal cell populationsare
ofobvious importance intryingto understand the induc-
tion ofaplasia and leukemia after exposure to benzene.
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